The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma
Moser, Justin C., Pulido, Jose S., Dronca, Roxana S., McWilliams, Robert R., Markovic, Svetomir N., Mansfield, Aaron S.Volume:
25
Langue:
english
Journal:
Melanoma Research
DOI:
10.1097/CMR.0000000000000125
Date:
February, 2015
Fichier:
PDF, 609 KB
english, 2015